Navigation Links
Safety Of Dental Amalgam Fillings To Be Reviewed

The Food and Drug administration (FDA) has asked a panel of outside experts to review the safety of dental amalgam fillings due to the persistent complaints that the fillings may cause health problems.//

The U.S. health officials found no evidence to suggest that the fillings were dangerous in dozen of studies conducted to review the safety of mercury in the silver fillings, and the FDA has asked the panel of outside experts to look into the matter to see if they agree with the findings or think there is reason for worry.

The silver fillings made with mercury is used to fill cavities in teeth in tens of millions of Americans each year as it is durable, easy to use, and relatively inexpensive when compared to tooth-colored fillings.

However, mercury is known to be toxic to brain and kidneys and because of this some consumers feel the use of mercury in dentistry is not warranted as there are other fillings available and are planning to file a petition asking the FDA to immediately ban them for pregnant women.

Charles Brown, Counsel for Consumers for Dental Choice, said if the FDA does not act, "we are going to still continue to use it in pregnant women and children even though we know mercury causes brain damage. It's morally and legally unacceptable."

Silver fillings along with fish consumption and vaccines has been listed as the major sources of mercury exposure in the United States by the FDA. However, health officials say that the mercury vapors emitted from fillings are too small to cause harm.

In a draft report prepared for the advisory panel meeting, the FDA said it has found no evidence to suggest that use of mercury in fillings is harmful. The agency said, "The weight of evidence does not support the hypothesis that exposure to mercury via dental amalgam restorations causes adverse biological outcomes."
SAR
'"/>




Page: 1

Related medicine news :

1. New standards for Human Research Safety
2. Safety of soy under suspicion
3. The Safety Of Prenatal Ultrasounds Questioned
4. Report on the Safety and Effectiveness of Melatonin supplements
5. Monitoring Drug Safety
6. Safety Of Indian Sex Workers At Risk Due To Poor Condom Usage
7. Safety Of Heart Drug Questioned
8. Race Was Used To Determine Safety Of Blood
9. Patient Safety Forces Closure Of Hospital
10. Farm Boy Airlifted by PSNI helicopter To Safety
11. Strict Safety Measures On Import of Poultry From China
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/20/2017)... ... 2017 , ... "TransFlare 4K Mystique comes with 44 colorful mysterious transitions that ... Christina Austin - CEO of Pixel Film Studios. , TransFlare 4K Mystique contains ... lens flare and light leak transitions have a very high-dynamic range for super smooth ...
(Date:1/20/2017)... ... ... a fine examination of how God handles sin, including how to let go of ... who, for over ten long years has been waiting to release this powerful insight about ... has been serving the Lord for over twenty years, and he has been preaching and ...
(Date:1/20/2017)... , ... January 20, 2017 , ... “The Land of ... attention to the issue of world hunger, and shares the simple and achievable answer. ... devoted husband and member of the Fairview Missionary Church in Angola, Indiana where he ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... and facility enhancement of their 503A compounding pharmacy located in Ocala, Florida. ... of physicians and patients throughout the United States for high-quality human anti-aging ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... has recently unveiled impressive transportable capabilities with their iMedHD2™ Portable Teleultrasound ... extension to RMT technology that delivers HD, dynamic, streaming ultrasound images and video ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 19, 2017 Incretin Mimetics/GLP-1 Agonists, SNDRIs, Lipase ... The global anti-obesity drugs market is expected to ... the forecast period and CAGR of 38.7% in the second half ... a CAGR of 32.8% from 2016 to 2027. The market is ... $24,063 million in 2027. ...
(Date:1/19/2017)... 2017  Sensus Healthcare, Inc. (NASDAQ: ... the treatment of non-melanoma skin cancers and other ... therapy, today announced that it will report its ... on Thursday, February 2, 2017 after the market close. ... call with the investment community on Thursday, February 2, ...
(Date:1/19/2017)... LONDON , January 19, 2017 ... New Therapeutic Option to Address Motor Symptoms and ... ...      (Logo: http://photos.prnewswire.com/prnh/20151014/276718LOGO) ... Fabrizio Stocchi , European Neurological Review,2016;11(Suppl. 2): 2-15, ...
Breaking Medicine Technology: